Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aarti Tarkar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biological Psychiatry|February 27, 2013
DYX1C1 placed in a molecular contextJoseph J LoTurco, Aarti Tarkar
Brain and Language|May 21, 2015
Deficits in learning and memory in mice with a mutation of the candidate dyslexia susceptibility gene Dyx1c1Amanda R Rendall, Aarti Tarkar, Hector M Contreras-Mora, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
British Journal of Cancer|May 26, 2023
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumorsAnthony B El-Khoueiry, James Clarke, Tobias Neff, et al.
Cell Chemical Biology|September 24, 2019
Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human HepatocytesFrançois Béliveau, Aarti Tarkar, Sébastien P Dion, et al.
Gynecologic Oncology|October 27, 2023
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)Leslie M Randall, David M O'Malley, Bradley J Monk, et al.
Blood|December 9, 2024
Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivationViral Shah, George Giotopoulos, Hikari Osaki, et al.
Nature Genetics|July 23, 2013
DYX1C1 is required for axonemal dynein assembly and ciliary motilityAarti Tarkar, Niki T Loges, Christopher E Slagle, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biological Psychiatry|February 27, 2013
DYX1C1 placed in a molecular contextJoseph J LoTurco, Aarti Tarkar
Brain and Language|May 21, 2015
Deficits in learning and memory in mice with a mutation of the candidate dyslexia susceptibility gene Dyx1c1Amanda R Rendall, Aarti Tarkar, Hector M Contreras-Mora, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
British Journal of Cancer|May 26, 2023
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumorsAnthony B El-Khoueiry, James Clarke, Tobias Neff, et al.
Cell Chemical Biology|September 24, 2019
Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human HepatocytesFrançois Béliveau, Aarti Tarkar, Sébastien P Dion, et al.
Gynecologic Oncology|October 27, 2023
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)Leslie M Randall, David M O'Malley, Bradley J Monk, et al.
Blood|December 9, 2024
Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivationViral Shah, George Giotopoulos, Hikari Osaki, et al.
Nature Genetics|July 23, 2013
DYX1C1 is required for axonemal dynein assembly and ciliary motilityAarti Tarkar, Niki T Loges, Christopher E Slagle, et al.
Pageof 1